KE — Kimball Electronics, Inc.

Earnings Call Summary for Kimball Electronics (Q3 2026)

1. Key Financial Results and Metrics:

• Net Sales: $353 million, a 3.4% sequential increase from Q2 2026, but a 6% decline year-over-year. Adjusting for a nonrecurring $24 million inventory sale in Q3 2025, sales increased nearly 1% year-over-year.
• Medical Segment: Sales of $106 million, representing 30% of total sales, with a 17% year-over-year growth after adjustments.
• Gross Margin: Improved to 7.9%, up from 7.2% in Q3 2025.
• Adjusted Operating Income: $14.8 million (4.2% of net sales), consistent with the previous year.
• Adjusted Net Income: $8 million or $0.33 per diluted share, compared to $6.8 million or $0.27 per diluted share last year.
• Cash Flow: Positive cash flow for the ninth consecutive quarter, with cash and cash equivalents at $82.5 million.
• Debt: Borrowings increased to $163 million but decreased by 9% year-over-year.

2. Strategic Updates and Business Highlights:

• Medical Vertical Growth: Continued focus on the Medical Contract Manufacturing Organization (CMO) as a strategic priority, with investments in capabilities and capacity.
• New Facility in Indianapolis: Expected to begin production by the end of 2026, aimed at enhancing manufacturing capabilities for medical devices.
• Customer Acquisition: Targeting to add five new customers annually in the Medical segment, with progress reported on this goal.
• Inorganic Growth: Ongoing evaluation of M&A opportunities to complement organic growth, particularly in the Medical sector.

3. Forward Guidance and Outlook:

• Fiscal 2026 Guidance: Affirmed revenue range of $1.4 billion to $1.46 billion, with adjusted operating income margin expected at the high end of 4.2% to 4.5%.
• Q4 Expectations: Anticipated sequential sales increase, particularly in the Medical vertical, despite external pressures.

4. Challenges and Points of Concern:

• Automotive Segment Decline: Sales decreased by 3% compared to Q3 2025, with concerns about demand for electronic steering systems amid changing consumer incentives and macroeconomic conditions.
• Industrial Segment Weakness: Sales down 8% year-over-year, primarily due to reduced demand for HVAC systems and off-highway equipment.
• Margin Pressure: Anticipated 40-50 basis point impact on gross margin in FY 2027 due to costs associated with ramping up the new facility.

5. Notable Q&A Insights:

• New Facility Capacity: The Indianapolis facility is expected to accommodate both existing and new programs, with a ramp-up timeline dependent on customer approvals and demand.
• Pricing Environment: Competitive but rational pricing in the Medical CMO space, with no signs of irrational pricing behavior noted.
• M&A Strategy: Actively pursuing opportunities that enhance capabilities and expand customer base, with a focus on geographic advantages and technology improvements.
• Medical Growth in Asia: Reported over 20% growth in the Medical segment in Asia for Q3, indicating strong demand in that region.

Overall, Kimball Electronics reported solid sequential growth driven by the Medical segment, while facing challenges in Automotive and Industrial sectors. The company remains optimistic about future growth and strategic initiatives, particularly in the Medical CMO space.